Illumina to acquire Peninsula cancer detection biotech Grail in $8 billion deal
September 21, 2020 at 11:08 AM EDT
The agreement comes after Menlo Park-based Grail filed plans earlier in September to go public later in the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|